July 12, 2023
Life Sciences | Tea Leaves
  • On Thursday, the Centers for Disease and Prevention (CDC) recommended that adults aged 60 and older get one of two respiratory syncytial virus (RSV) vaccines this fall, making them the first shots against the disease to be authorized in the U.S. The Food and Drug Administration (FDA) has approved the vaccines from GlaxoSmithKline and Pfizer. The CDC said older adults should first consult with their doctors if the shot is right for them. A vaccine for children, who are also at elevated risk, has not been approved in the U.S.; however, FDA advisers in May endorsed giving pregnant people an experimental Pfizer vaccine to protect infants. (Article here)